(Q37760788)

22 August 2017

title

Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

22 August 2017

main subject

0 references

4

Tamara Arenovich

1 reference

22 August 2017

Teru Kumagi

1

1 reference

22 August 2017

Maha Guindi

2

1 reference

22 August 2017

Sandra E Fischer

3

1 reference

22 August 2017

Rupert Abdalian

5

1 reference

22 August 2017

Catalina Coltescu

6

1 reference

22 August 2017

E Jenny Heathcote

7

1 reference

22 August 2017

Gideon M Hirschfield

8

1 reference

22 August 2017

language of work or name

English

0 references

publication date

25 May 2010

1 reference

The American Journal of Gastroenterology

22 August 2017

published in

1 reference

22 August 2017

volume

105

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

2186-2194

1 reference

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Prognosis in primary biliary cirrhosis: model for decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.216

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.216

1 reference

release_ab3z5yoqwzajlhfmgkoz2pcwmq

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ab3z5yoqwzajlhfmgkoz2pcwmq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference